Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 215

1.

Platelet Activation Is Limited during Transcatheter Aortic Valve Implantation in Patients on Aspirin Monotherapy and without per Procedural Clinical Complications.

Dumonteil N, Levade M, Garcia C, Lhermusier T, Series J, Le Faouder P, Marcheix B, Payrastre B, Carrié D, Sié P.

TH Open. 2019 May 30;3(2):e146-e152. doi: 10.1055/s-0039-1692142. eCollection 2019 Apr.

2.

Differences and similarities in ibrutinib and acalabrutinib effects on platelet functions.

Series J, Garcia C, Levade M, Viaud J, Sié P, Ysebaert L, Payrastre B.

Haematologica. 2019 Feb 28. pii: haematol.2018.207183. doi: 10.3324/haematol.2018.207183. [Epub ahead of print]

3.

Platelet activation and prothrombotic properties in a mouse model of peritoneal sepsis.

Vardon Bounes F, Mémier V, Marcaud M, Jacquemin A, Hamzeh-Cognasse H, Garcia C, Series J, Sié P, Minville V, Gratacap MP, Payrastre B.

Sci Rep. 2018 Sep 10;8(1):13536. doi: 10.1038/s41598-018-31910-8.

4.

Management of bleeding and emergency invasive procedures in patients on dabigatran: Updated guidelines from the French Working Group on Perioperative Haemostasis (GIHP) - September 2016.

Albaladejo P, Pernod G, Godier A, de Maistre E, Rosencher N, Mas JL, Fontana P, Samama CM, Steib A, Schlumberger S, Marret E, Roullet S, Susen S, Madi-Jebara S, Nguyen P, Schved JF, Bonhomme F, Sié P; members of the French Working Group on Perioperative Haemostasis.

Anaesth Crit Care Pain Med. 2018 Aug;37(4):391-399. doi: 10.1016/j.accpm.2018.04.009. Epub 2018 May 2. Review.

5.

Comparison of the ecarin chromogenic assay and diluted thrombin time for quantification of dabigatran concentrations: comment.

Marlu R, Jouve T, Polack B, Sié P, Mémier V.

J Thromb Haemost. 2018 May;16(5):1017-1019. doi: 10.1111/jth.13981. Epub 2018 Mar 24. No abstract available.

PMID:
29460346
6.

Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants.

Touzé E, Gruel Y, Gouin-Thibault I, De Maistre E, Susen S, Sie P, Derex L.

Eur J Neurol. 2018 May;25(5):747-e52. doi: 10.1111/ene.13582. Epub 2018 Mar 9.

PMID:
29360254
7.

Postauthorization safety study of Clottafact® , a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational study.

Négrier C, Ducloy-Bouthors AS, Piriou V, De Maistre E, Stieltjes N, Borel-Derlon A, Colson P, Picard J, Lambert T, Claeyssens S, Boileau S, Bertrand A, André MH, Fourrier F, Ozier Y, Sié P, Gruel Y, Tellier Z.

Vox Sang. 2018 Feb;113(2):120-127. doi: 10.1111/vox.12624. Epub 2017 Dec 13.

PMID:
29238971
8.

Evaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French study.

Gouin-Thibault I, Freyburger G, de Maistre E, Susen S, Delavenne X, Golmard JL, Gruel Y, Sié P; GFHT study group on DOAC.

Thromb Res. 2017 Oct;158:126-133. doi: 10.1016/j.thromres.2017.09.001. Epub 2017 Sep 4.

PMID:
28892657
9.

Management of Severe Bleeding in Patients Treated with Direct Oral Anticoagulants: An Observational Registry Analysis.

Albaladejo P, Samama CM, Sié P, Kauffmann S, Mémier V, Suchon P, Viallon A, David JS, Gruel Y, Bellamy L, de Maistre E, Romegoux P, Thoret S, Pernod G, Bosson JL; GIHP-NACO Study Group.

Anesthesiology. 2017 Jul;127(1):111-120. doi: 10.1097/ALN.0000000000001631.

PMID:
28410272
10.

Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) - September 2015.

Albaladejo P, Bonhomme F, Blais N, Collet JP, Faraoni D, Fontana P, Godier A, Llau J, Longrois D, Marret E, Mismetti P, Rosencher N, Roullet S, Samama CM, Schved JF, Sié P, Steib A, Susen S; French Working Group on Perioperative Hemostasis (GIHP).

Anaesth Crit Care Pain Med. 2017 Feb;36(1):73-76. doi: 10.1016/j.accpm.2016.09.002. Epub 2016 Sep 20.

11.

Post-authorization safety study of Clottafact® , a triply secured fibrinogen concentrate in congenital afibrinogenemia. A prospective observational study.

Négrier C, Rothschild C, Borg JY, Lambert T, Claeyssens S, Sanhes L, Stieltjes N, Bertrand A, André MH, Sié P, Gruel Y, Tellier Z.

Vox Sang. 2016 Nov;111(4):383-390. doi: 10.1111/vox.12424. Epub 2016 Sep 1.

PMID:
27583698
12.

Spotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatran.

Sié P.

Drug Des Devel Ther. 2016 May 18;10:1683-9. doi: 10.2147/DDDT.S94167. eCollection 2016. Review.

13.

A diagnostic approach that may help to discriminate inherited thrombocytopenia from chronic immune thrombocytopenia in adult patients.

Fiore M, Pillois X, Lorrain S, Bernard MA, Moore N, Sié P, Viallard JF, Nurden P.

Platelets. 2016 Sep;27(6):555-62. doi: 10.3109/09537104.2016.1143920. Epub 2016 Mar 30.

PMID:
27025585
14.

The class I phosphoinositide 3-kinases α and β control antiphospholipid antibodies-induced platelet activation.

Terrisse AD, Laurent PA, Garcia C, Gratacap MP, Vanhaesebroeck B, Sié P, Payrastre B.

Thromb Haemost. 2016 Jun 2;115(6):1138-46. doi: 10.1160/TH15-08-0661. Epub 2016 Jan 28.

PMID:
26818901
15.

ATP-binding cassette transporter 1 (ABCA1) deficiency decreases platelet reactivity and reduces thromboxane A2 production independently of hematopoietic ABCA1.

Lhermusier T, Severin S, Van Rothem J, Garcia C, Bertrand-Michel J, Le Faouder P, Hechler B, Broccardo C, Couvert P, Chimini G, Sié P, Payrastre B.

J Thromb Haemost. 2016 Mar;14(3):585-95. doi: 10.1111/jth.13247. Epub 2016 Feb 17.

16.

Platelet Adhesion and Thrombus Formation in Whole Blood at Arterial Shear Rate at the End of Pregnancy.

Valéra MC, Parant O, Cenac C, Arnaud C, Gallini A, Hamdi S, Sié P, Arnal JF, Payrastre B.

Am J Reprod Immunol. 2015 Dec;74(6):533-41. doi: 10.1111/aji.12433. Epub 2015 Oct 4.

PMID:
26435170
17.

[Laboratory coagulation tests in patients treated by direct oral anticoagulants (DOACs)].

Sié P.

Presse Med. 2015 Jul-Aug;44(7-8):772-8. doi: 10.1016/j.lpm.2015.06.004. Epub 2015 Aug 3. Review. French.

PMID:
26248706
18.

Expanding the Mutation Spectrum Affecting αIIbβ3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort.

Nurden AT, Pillois X, Fiore M, Alessi MC, Bonduel M, Dreyfus M, Goudemand J, Gruel Y, Benabdallah-Guerida S, Latger-Cannard V, Négrier C, Nugent D, Oiron RD, Rand ML, Sié P, Trossaert M, Alberio L, Martins N, Sirvain-Trukniewicz P, Couloux A, Canault M, Fronthroth JP, Fretigny M, Nurden P, Heilig R, Vinciguerra C.

Hum Mutat. 2015 May;36(5):548-61. doi: 10.1002/humu.22776.

19.

Ibrutinib treatment affects collagen and von Willebrand factor-dependent platelet functions.

Levade M, David E, Garcia C, Laurent PA, Cadot S, Michallet AS, Bordet JC, Tam C, Sié P, Ysebaert L, Payrastre B.

Blood. 2014 Dec 18;124(26):3991-5. doi: 10.1182/blood-2014-06-583294. Epub 2014 Oct 10.

PMID:
25305202
20.

Platelet activation and arterial peripheral serotonin turnover in cardiac remodeling associated to aortic stenosis.

Rouzaud-Laborde C, Delmas C, Pizzinat N, Tortosa F, Garcia C, Mialet-Perez J, Payrastre B, Sié P, Spreux-Varoquaux O, Sallerin B, Carrié D, Galinier M, Parini A, Lairez O.

Am J Hematol. 2015 Jan;90(1):15-9. doi: 10.1002/ajh.23855.

21.

Switching patients from clopidogrel to novel P2Y12 receptor inhibitors in acute coronary syndrome: comparative effects of prasugrel and ticagrelor on platelet reactivity.

Lhermusier T, Voisin S, Murat G, Mejean S, Garcia C, Bataille V, Lipinski MJ, Carrié D, Sié P.

Int J Cardiol. 2014 Jul 1;174(3):874-6. doi: 10.1016/j.ijcard.2014.04.208. Epub 2014 Apr 26. No abstract available.

PMID:
24820749
22.

Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia.

Noris P, Schlegel N, Klersy C, Heller PG, Civaschi E, Pujol-Moix N, Fabris F, Favier R, Gresele P, Latger-Cannard V, Cuker A, Nurden P, Greinacher A, Cattaneo M, De Candia E, Pecci A, Hurtaud-Roux MF, Glembotsky AC, Muñiz-Diaz E, Randi ML, Trillot N, Bury L, Lecompte T, Marconi C, Savoia A, Balduini CL, Bayart S, Bauters A, Benabdallah-Guedira S, Boehlen F, Borg JY, Bottega R, Bussel J, De Rocco D, de Maistre E, Faleschini M, Falcinelli E, Ferrari S, Ferster A, Fierro T, Fleury D, Fontana P, James C, Lanza F, Le Cam Duchez V, Loffredo G, Magini P, Martin-Coignard D, Menard F, Mercier S, Mezzasoma A, Minuz P, Nichele I, Notarangelo LD, Pippucci T, Podda GM, Pouymayou C, Rigouzzo A, Royer B, Sie P, Siguret V, Trichet C, Tucci A, Saposnik B, Veneri D; European Hematology Association – Scientific Working Group on Thrombocytopenias and Platelet Function Disorders.

Haematologica. 2014 Aug;99(8):1387-94. doi: 10.3324/haematol.2014.105924. Epub 2014 Apr 24.

23.

[Perioperative management of new oral anticoagulants].

Samama CM, Pernod G, Albaladejo P, Sie P; Groupe d’intérêt en hémostase péri-opératoire (GIHP).

Presse Med. 2014 Jun;43(6 Pt 1):637-44. doi: 10.1016/j.lpm.2013.11.025. Epub 2014 Apr 16. Review. French.

PMID:
24742616
24.

[Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors. Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013].

Pernod G, Albaladejo P, Godier A, Samama CM, Susen S, Gruel Y, Blais N, Fontana P, Cohen A, Llau JV, Rosencher N, Schved JF, de Maistre E, Samama MM, Mismetti P, Sié P.

Ann Fr Anesth Reanim. 2013 Oct;32(10):691-700. doi: 10.1016/j.annfar.2013.04.016. Epub 2013 Aug 30. Review. French. Erratum in: Ann Fr Anesth Reanim. 2014 Mar;33(3):198-9.

PMID:
23993157
25.

Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.

Pernod G, Albaladejo P, Godier A, Samama CM, Susen S, Gruel Y, Blais N, Fontana P, Cohen A, Llau JV, Rosencher N, Schved JF, de Maistre E, Samama MM, Mismetti P, Sié P; Working Group on Perioperative Haemostasis.

Arch Cardiovasc Dis. 2013 Jun-Jul;106(6-7):382-93. doi: 10.1016/j.acvd.2013.04.009. Epub 2013 Jun 25.

26.

[Questions--answers on the use of rivaroxaban for the treatment of venous thromboembolic disease].

Pernod G, Elias A, Gouin I, Gaillard C, Nguyen P, Ouvry P, Sié P.

J Mal Vasc. 2012 Dec;37(6):300-10. doi: 10.1016/j.jmv.2012.09.003. Epub 2012 Nov 2. French.

PMID:
23122646
27.

Large psoas haematoma and femoral neuropathy in a patient with type 2B von Willebrand's disease.

Pailhes R, Lafosse JM, Marty P, Dahan O, Voisin S, Sié P.

Haemophilia. 2012 Nov;18(6):e407-8. doi: 10.1111/hae.12022. Epub 2012 Sep 25. No abstract available.

PMID:
23005922
28.

Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the hematopoietic estrogen receptor α.

Valéra MC, Gratacap MP, Gourdy P, Lenfant F, Cabou C, Toutain CE, Marcellin M, Saint Laurent N, Sié P, Sixou M, Arnal JF, Payrastre B.

Blood. 2012 Aug 23;120(8):1703-12. doi: 10.1182/blood-2012-01-405498. Epub 2012 Jul 9.

PMID:
22776819
29.

Switching patients from clopidogrel to prasugrel in acute coronary syndrome: effects of prasugrel loading dose on residual platelet reactivity.

Lhermusier T, Voisin S, Mejean S, Garcia C, Sié P, Carrié D.

J Thromb Haemost. 2012 Sep;10(9):1946-9. doi: 10.1111/j.1538-7836.2012.04838.x. No abstract available.

30.

Inherited platelet disorders and oral health.

Valera MC, Kemoun P, Cousty S, Sie P, Payrastre B.

J Oral Pathol Med. 2013 Feb;42(2):115-24. doi: 10.1111/j.1600-0714.2012.01151.x. Epub 2012 May 15. Review.

PMID:
22583386
31.

[Renal biopsy practice: results of a French study and recommendations].

Bollée G, Moulin B, Martinez F, Meulders Q, Rougier JP, Baumelou A, Glotz D, Subra JF, Ulinski T, Vrigneaud L, Brasseur J, Alhenc-Gelas M, Martin L, Daniel L, Kourilsky O, Deteix P, Sie P, Ronco P, Houillier P; Groupe de travail de la Société de Néphrologie.

Nephrol Ther. 2012 Jun;8(3):168-76. doi: 10.1016/j.nephro.2011.12.005. Epub 2012 Mar 16. French.

PMID:
22425459
32.

Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Recommendations of the Working Group on Perioperative Haemostasis and the French Study Group on Thrombosis and Haemostasis.

Sié P, Samama CM, Godier A, Rosencher N, Steib A, Llau JV, Van der Linden P, Pernod G, Lecompte T, Gouin-Thibault I, Albaladejo P; Working Group on Perioperative Haemostasis; French Study Group on Thrombosis and Haemostasis.

Arch Cardiovasc Dis. 2011 Dec;104(12):669-76. doi: 10.1016/j.acvd.2011.09.001. Epub 2011 Oct 29.

33.

The Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin-PF4 complex directed antibodies.

Lhermusier T, van Rottem J, Garcia C, Xuereb JM, Ragab A, Martin V, Gratacap MP, Sié P, Payrastre B.

J Thromb Haemost. 2011 Oct;9(10):2067-76. doi: 10.1111/j.1538-7836.2011.04470.x.

34.

[Surgery and invasive procedures in patients on long-term treatment with oral direct thrombin or factor Xa inhibitors].

Sié P, Samama CM, Godier A, Rosencher N, Steib A, Llau JV, van der Linden P, Pernod G, Lecompte T, Gouin-Thibault I, Albaladejo P.

Ann Fr Anesth Reanim. 2011 Sep;30(9):645-50. doi: 10.1016/j.annfar.2011.06.018. Epub 2011 Aug 5. Review. French.

PMID:
21820844
35.

Are P2Y12 reaction unit (PRU) and % inhibition index equivalent for the expression of P2Y12 inhibition by the VerifyNow assay? Role of haematocrit and haemoglobin levels.

Voisin S, Bongard V, Tidjane MA, Lhermusier T, Carrié D, Sié P.

Thromb Haemost. 2011 Aug;106(2):227-9. doi: 10.1160/TH11-01-0046. Epub 2011 May 5.

PMID:
21544318
36.

Short-term effects of the smoke-free legislation on haemostasis and systemic inflammation due to second hand smoke exposure. The AERER study.

Cayla G, Sié P, Silvain J, Brugier D, Cambou JP, Thomas D, Pena A, O'Connor SA, Bura A, Ruidavets JB, Montalescot G, Collet JP.

Thromb Haemost. 2011 Jun;105(6):1024-31. doi: 10.1160/TH11-02-0062. Epub 2011 Apr 20.

PMID:
21505721
37.

More on: adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel.

Tidjane MA, Voisin S, Lhermusier T, Bongard V, Sié P, Carrié D.

J Thromb Haemost. 2011 Mar;9(3):614-6. doi: 10.1111/j.1538-7836.2010.04180.x. No abstract available.

38.

Internalization of microparticles by endothelial cells promotes platelet/endothelial cell interaction under flow.

Terrisse AD, Puech N, Allart S, Gourdy P, Xuereb JM, Payrastre B, Sié P.

J Thromb Haemost. 2010 Dec;8(12):2810-9. doi: 10.1111/j.1538-7836.2010.04088.x.

39.

French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding).

Pernod G, Godiér A, Gozalo C, Tremey B, Sié P; French National Authority for Health.

Thromb Res. 2010 Sep;126(3):e167-74. doi: 10.1016/j.thromres.2010.06.017. Epub 2010 Jul 14. Review.

PMID:
20630568
40.

Renal biopsy practice in France: results of a nationwide study.

Bollée G, Martinez F, Moulin B, Meulders Q, Rougier JP, Baumelou A, Glotz D, Subra JF, Ulinski T, Vrigneaud L, Brasseur J, Martin L, Daniel L, Kourilsky O, Deteix P, Sie P, Ronco P, Houillier P.

Nephrol Dial Transplant. 2010 Nov;25(11):3579-85. doi: 10.1093/ndt/gfq254. Epub 2010 May 11.

PMID:
20466684
41.

The new tyrosine-kinase inhibitor and anticancer drug dasatinib reversibly affects platelet activation in vitro and in vivo.

Gratacap MP, Martin V, Valéra MC, Allart S, Garcia C, Sié P, Recher C, Payrastre B.

Blood. 2009 Aug 27;114(9):1884-92. doi: 10.1182/blood-2009-02-205328. Epub 2009 Jun 3.

PMID:
19494352
42.

Association of neutrophil count with microembolization in patients with symptomatic carotid artery stenosis.

Nasr N, Ruidavets JB, Arnal JF, Sie P, Larrue V.

Atherosclerosis. 2009 Dec;207(2):519-23. doi: 10.1016/j.atherosclerosis.2009.05.003. Epub 2009 May 13.

PMID:
19486978
43.

Assessment of platelet response to clopidogrel through measurement of ADP-induced Akt phosphorylation.

Carrié D, Garcia C, Gratacap MP, Voisin S, Payrastre B, Sié P.

J Thromb Haemost. 2009 Aug;7(8):1411-3. doi: 10.1111/j.1538-7836.2009.03485.x. Epub 2009 May 15. No abstract available.

44.
45.

Understanding the controversy about hormonal replacement therapy: insights from estrogen effects on experimental and clinical atherosclerosis.

Arnal JF, Douin-Echinard V, Tremollières F, Terrisse AD, Sié P, Payrastre B, Guery JC, Bayard F, Gourdy P.

Arch Mal Coeur Vaiss. 2007 Jun-Jul;100(6-7):554-62. Review.

PMID:
17893638
46.

Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies.

Sanmarco M, Gayet S, Alessi MC, Audrain M, de Maistre E, Gris JC, de Groot PG, Hachulla E, Harlé JR, Sié P, Boffa MC.

Thromb Haemost. 2007 Jun;97(6):949-54.

PMID:
17549297
47.

[Reference center for platelet diseases].

Nurden P, Dreyfus M, Favier R, Négrier C, Schlégel N, Sie P, Nurden A.

Arch Pediatr. 2007 Jun;14(6):679-82. Epub 2007 Apr 6. French. No abstract available.

PMID:
17419014
48.

Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals.

Tavassoli N, Duchayne E, Sadaba B, Desboeuf K, Sommet A, Lapeyre-Mestre M, Muoz MJ, Sie P, Honorato J, Montastruc JL, Bagheri H.

Eur J Clin Pharmacol. 2007 Mar;63(3):221-8. Epub 2007 Jan 17.

PMID:
17225990
49.

Central laboratory and point of care assessment of perioperative hemostasis.

Sié P, Steib A.

Can J Anaesth. 2006 Jun;53(6 Suppl):S12-20. Review.

PMID:
16766785
50.

Supplemental Content

Support Center